Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Custom Oligonucleotide Synthesis and Gene Synthesis Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oligonucleotide Synthesis
1.2.3 Gene Synthesis
1.3 Market Segmentation by Application
1.3.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Oligonucleotide Synthesis Market Size by Players
3.3.2 Gene Synthesis Market Size by Players
3.4 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type (2020-2031)
6.4 North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type (2020-2031)
7.4 Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type (2020-2031)
9.4 Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Genescript
11.1.1 Genescript Corporation Information
11.1.2 Genescript Business Overview
11.1.3 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.1.4 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.1.5 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Product in 2024
11.1.6 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application in 2024
11.1.7 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Geographic Area in 2024
11.1.8 Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
11.1.9 Genescript Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.2.4 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 IDT
11.3.1 IDT Corporation Information
11.3.2 IDT Business Overview
11.3.3 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.3.4 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.3.5 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Product in 2024
11.3.6 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application in 2024
11.3.7 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Geographic Area in 2024
11.3.8 IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
11.3.9 IDT Recent Developments
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Corporation Information
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.4.4 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.4.5 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Product in 2024
11.4.6 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application in 2024
11.4.7 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Geographic Area in 2024
11.4.8 Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
11.4.9 Eurofins Genomics Recent Developments
11.5 DNA 2.0 (ATUM)
11.5.1 DNA 2.0 (ATUM) Corporation Information
11.5.2 DNA 2.0 (ATUM) Business Overview
11.5.3 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.5.4 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.5.5 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Product in 2024
11.5.6 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application in 2024
11.5.7 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Geographic Area in 2024
11.5.8 DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
11.5.9 DNA 2.0 (ATUM) Recent Developments
11.6 BBI
11.6.1 BBI Corporation Information
11.6.2 BBI Business Overview
11.6.3 BBI Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.6.4 BBI Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.6.5 BBI Recent Developments
11.7 Azenta Life Sciences
11.7.1 Azenta Life Sciences Corporation Information
11.7.2 Azenta Life Sciences Business Overview
11.7.3 Azenta Life Sciences Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.7.4 Azenta Life Sciences Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.7.5 Azenta Life Sciences Recent Developments
11.8 SBS Genetech
11.8.1 SBS Genetech Corporation Information
11.8.2 SBS Genetech Business Overview
11.8.3 SBS Genetech Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.8.4 SBS Genetech Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.8.5 SBS Genetech Recent Developments
11.9 Bio Basic
11.9.1 Bio Basic Corporation Information
11.9.2 Bio Basic Business Overview
11.9.3 Bio Basic Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.9.4 Bio Basic Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.9.5 Bio Basic Recent Developments
11.10 Twist Bioscience
11.10.1 Twist Bioscience Corporation Information
11.10.2 Twist Bioscience Business Overview
11.10.3 Twist Bioscience Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.10.4 Twist Bioscience Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 OriGene
11.11.1 OriGene Corporation Information
11.11.2 OriGene Business Overview
11.11.3 OriGene Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.11.4 OriGene Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.11.5 OriGene Recent Developments
11.12 Bioneer
11.12.1 Bioneer Corporation Information
11.12.2 Bioneer Business Overview
11.12.3 Bioneer Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.12.4 Bioneer Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.12.5 Bioneer Recent Developments
11.13 Eton Bioscience
11.13.1 Eton Bioscience Corporation Information
11.13.2 Eton Bioscience Business Overview
11.13.3 Eton Bioscience Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.13.4 Eton Bioscience Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.13.5 Eton Bioscience Recent Developments
11.14 Synbio Technologies
11.14.1 Synbio Technologies Corporation Information
11.14.2 Synbio Technologies Business Overview
11.14.3 Synbio Technologies Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.14.4 Synbio Technologies Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.14.5 Synbio Technologies Recent Developments
11.15 Eurogentec
11.15.1 Eurogentec Corporation Information
11.15.2 Eurogentec Business Overview
11.15.3 Eurogentec Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Features and Attributes
11.15.4 Eurogentec Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue and Gross Margin (2020-2025)
11.15.5 Eurogentec Recent Developments
12 Custom Oligonucleotide Synthesis and Gene Synthesis ServiceIndustry Chain Analysis
12.1 Custom Oligonucleotide Synthesis and Gene Synthesis Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Oligonucleotide Synthesis and Gene Synthesis Service as of 2024)
Table 11. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Companies Headquarters
Table 13. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Custom Oligonucleotide Synthesis and Gene Synthesis Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Growth Accelerators and Market Barriers
Table 25. North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Growth Accelerators and Market Barriers
Table 27. Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Investment Opportunities and Key Challenges
Table 31. Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Genescript Corporation Information
Table 35. Genescript Description and Major Businesses
Table 36. Genescript Product Features and Attributes
Table 37. Genescript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Genescript Revenue Proportion by Product in 2024
Table 39. Genescript Revenue Proportion by Application in 2024
Table 40. Genescript Revenue Proportion by Geographic Area in 2024
Table 41. Genescript Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
Table 42. Genescript Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. IDT Corporation Information
Table 53. IDT Description and Major Businesses
Table 54. IDT Product Features and Attributes
Table 55. IDT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. IDT Revenue Proportion by Product in 2024
Table 57. IDT Revenue Proportion by Application in 2024
Table 58. IDT Revenue Proportion by Geographic Area in 2024
Table 59. IDT Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
Table 60. IDT Recent Developments
Table 61. Eurofins Genomics Corporation Information
Table 62. Eurofins Genomics Description and Major Businesses
Table 63. Eurofins Genomics Product Features and Attributes
Table 64. Eurofins Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Eurofins Genomics Revenue Proportion by Product in 2024
Table 66. Eurofins Genomics Revenue Proportion by Application in 2024
Table 67. Eurofins Genomics Revenue Proportion by Geographic Area in 2024
Table 68. Eurofins Genomics Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
Table 69. Eurofins Genomics Recent Developments
Table 70. DNA 2.0 (ATUM) Corporation Information
Table 71. DNA 2.0 (ATUM) Description and Major Businesses
Table 72. DNA 2.0 (ATUM) Product Features and Attributes
Table 73. DNA 2.0 (ATUM) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. DNA 2.0 (ATUM) Revenue Proportion by Product in 2024
Table 75. DNA 2.0 (ATUM) Revenue Proportion by Application in 2024
Table 76. DNA 2.0 (ATUM) Revenue Proportion by Geographic Area in 2024
Table 77. DNA 2.0 (ATUM) Custom Oligonucleotide Synthesis and Gene Synthesis Service SWOT Analysis
Table 78. DNA 2.0 (ATUM) Recent Developments
Table 79. BBI Corporation Information
Table 80. BBI Description and Major Businesses
Table 81. BBI Product Features and Attributes
Table 82. BBI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. BBI Recent Developments
Table 84. Azenta Life Sciences Corporation Information
Table 85. Azenta Life Sciences Description and Major Businesses
Table 86. Azenta Life Sciences Product Features and Attributes
Table 87. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Azenta Life Sciences Recent Developments
Table 89. SBS Genetech Corporation Information
Table 90. SBS Genetech Description and Major Businesses
Table 91. SBS Genetech Product Features and Attributes
Table 92. SBS Genetech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. SBS Genetech Recent Developments
Table 94. Bio Basic Corporation Information
Table 95. Bio Basic Description and Major Businesses
Table 96. Bio Basic Product Features and Attributes
Table 97. Bio Basic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Bio Basic Recent Developments
Table 99. Twist Bioscience Corporation Information
Table 100. Twist Bioscience Description and Major Businesses
Table 101. Twist Bioscience Product Features and Attributes
Table 102. Twist Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Twist Bioscience Recent Developments
Table 104. OriGene Corporation Information
Table 105. OriGene Description and Major Businesses
Table 106. OriGene Product Features and Attributes
Table 107. OriGene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. OriGene Recent Developments
Table 109. Bioneer Corporation Information
Table 110. Bioneer Description and Major Businesses
Table 111. Bioneer Product Features and Attributes
Table 112. Bioneer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Bioneer Recent Developments
Table 114. Eton Bioscience Corporation Information
Table 115. Eton Bioscience Description and Major Businesses
Table 116. Eton Bioscience Product Features and Attributes
Table 117. Eton Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Eton Bioscience Recent Developments
Table 119. Synbio Technologies Corporation Information
Table 120. Synbio Technologies Description and Major Businesses
Table 121. Synbio Technologies Product Features and Attributes
Table 122. Synbio Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Synbio Technologies Recent Developments
Table 124. Eurogentec Corporation Information
Table 125. Eurogentec Description and Major Businesses
Table 126. Eurogentec Product Features and Attributes
Table 127. Eurogentec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Eurogentec Recent Developments
Table 129. Raw Materials Key Suppliers
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources


List of Figures
Figure 1. Custom Oligonucleotide Synthesis and Gene Synthesis Service Product Picture
Figure 2. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Oligonucleotide Synthesis Product Picture
Figure 4. Gene Synthesis Product Picture
Figure 5. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Commercial
Figure 7. Academic Research
Figure 8. Custom Oligonucleotide Synthesis and Gene Synthesis Service Report Years Considered
Figure 9. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 11. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Market Share by Region (2020-2031)
Figure 13. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. Oligonucleotide Synthesis Revenue Market Share by Player in 2024
Figure 16. Gene Synthesis Revenue Market Share by Player in 2024
Figure 17. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Market Share by Type (2020-2031)
Figure 18. Global Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue Market Share by Application (2020-2031)
Figure 19. North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) in 2024
Figure 21. North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) in 2024
Figure 28. Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 31. France Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 43. India Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) in 2024
Figure 51. Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) in 2024
Figure 57. South America Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Custom Oligonucleotide Synthesis and Gene Synthesis Service Revenue (2020-2025) & (US$ Million)
Figure 63. Custom Oligonucleotide Synthesis and Gene Synthesis Service Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit